FDA-approved drug may finally help immunotherapy defeat rare liver cancer

A rare and aggressive form of liver cancer has long resisted immunotherapy, a treatment that helps the body’s own immune system attack cancer cells. Now, researchers have identified a potential way to overcome that resistance using an FDA-approved drug that is already available for another…

Click here to view the original article.